Keith Flaherty to become president-elect of AACR for 2025-2026, Michael Caligiuri named treasurer

Targeting FGFR2 may prevent or delay some KRAS-mutated pancreatic cancers

Precancerous pancreatic lesions and some pancreatic ductal adenocarcinoma tumors harboring KRAS mutations had higher-than-normal expression of the FGFR2 protein, and FGFR2 inactivation delayed KRAS-mutated PDAC development in mice, according to results of a study published in Cancer Research, a journal of the American Association for Cancer Research.

April 04, 2025

Vol.51 No.13

Guest Editorial

Rathmell: My mentor recognized a cliff I was going to fall off before I did.
“He was there to stand with me while I fell, and then made me look up and see that I needed to lean into the experience.”

I was really excited to get to talk about the role that mentorship plays in women’s leadership development. It’s a topic that I’ve thought a lot about, and also that I’ve benefitted from, and that I think is not always applied with enough intention. There is an art to mentorship, and I want to share some of how that has helped me navigate career transitions and pivot to leadership roles.

March 14, 2025

Vol.51 No.10

By W. Kimryn Rathmell

In Brief

AACR names 2025 fellows of AACR Academy, AACR Academy president

The American Association for Cancer Research named its newly elected 2025 class of fellows of the AACR Academy.

March 14, 2025

Vol.51 No.10

Capitol Hill White House

Amid funding cuts and firings, cancer groups seek relief from judges, in Congress—and in the court of public opinion

As NCI employees and others at HHS were receiving notices of termination, national cancer organizations called on Congress “to restore stability to NIH.”

February 21, 2025

Vol.51 No.07

By Claire Marie Porter, Jacquelyn Cobb and Paul Goldberg

In Brief

Daniel Nomura named editor-in-chief of Molecular Cancer Therapeutics

Daniel K. Nomura was named editor-in-chief of Molecular Cancer Therapeutics, one of the 10 journals published by the American Association for Cancer Research.

February 14, 2025

Vol.51 No.06

Clinical Roundup

Preclinical data suggest WRN inhibitor may be viable treatment for MSI-H tumors

Preclinical data on a development candidate, NTX-452, a novel Werner syndrome helicase inhibitor, was presented at the 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, by Nimbus Therapeutics.

October 25, 2024

Vol.50 No.40

Keith Flaherty to become president-elect of AACR for 2025-2026, Michael Caligiuri named treasurer

YOU MAY BE INTERESTED IN

Targeting FGFR2 may prevent or delay some KRAS-mutated pancreatic cancers

Rathmell: My mentor recognized a cliff I was going to fall off before I did.
“He was there to stand with me while I fell, and then made me look up and see that I needed to lean into the experience.”

AACR names 2025 fellows of AACR Academy, AACR Academy president

Amid funding cuts and firings, cancer groups seek relief from judges, in Congress—and in the court of public opinion

Daniel Nomura named editor-in-chief of Molecular Cancer Therapeutics

Preclinical data suggest WRN inhibitor may be viable treatment for MSI-H tumors

Renew today!

Subscriber content

Keith Flaherty to become president-elect of AACR for 2025-2026, Michael Caligiuri named treasurer

YOU MAY BE INTERESTED IN

Targeting FGFR2 may prevent or delay some KRAS-mutated pancreatic cancers

Rathmell: My mentor recognized a cliff I was going to fall off before I did.“He was there to stand with me while I fell, and then made me look up and see that I needed to lean into the experience.”

AACR names 2025 fellows of AACR Academy, AACR Academy president

Amid funding cuts and firings, cancer groups seek relief from judges, in Congress—and in the court of public opinion

Daniel Nomura named editor-in-chief of Molecular Cancer Therapeutics

Preclinical data suggest WRN inhibitor may be viable treatment for MSI-H tumors

Rathmell: My mentor recognized a cliff I was going to fall off before I did.
“He was there to stand with me while I fell, and then made me look up and see that I needed to lean into the experience.”